Stay updated with breaking news from Cassava Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Cassava Sciences, Inc. announced top-line clinical results from its Cognition Maintenance Study . The CMS is a small proof-of-concept study designed to demonstrate the effects of drug versus placebo...
-- AXT said it has addressed the potential impact of the announcement of China's new export control regulations on gallium- and germanium-related materials, which take effect on Aug. 1. In Q1,...
The company announced phase 3 trial results for its lead Alzheimer's therapy.
The company announced phase 3 trial results for its lead Alzheimer's therapy.
Byrne Asset Management LLC cut its position in Cassava Sciences, Inc. (NASDAQ:SAVA – Get Rating) by 27.8% during the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 1,945 shares of the company’s stock after selling 749 shares during the quarter. Byrne Asset Management […]